Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...
The IFA has formally called on the Federal Trade Commission to shift its focus away from increased regulation of the franchise business model, arguing that the commission's recent actions exceed its ...